Erratum to: Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods

Liu, Yiping; Zeng, Liang; Zhang, Shusheng; Zeng, Shan; Huang, Jin; Tang, Youhong; Zhong, Meizuo
December 2013
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
Academic Journal
Correction notice
No abstract available.


Related Articles

  • Reprogrammed chemoresistant DLBCL cells responded to chemotherapy.  // Hem/Onc Today;10/25/2013, Vol. 14 Issue 20, p45 

    The article presents the results of the study as of late October 2013, which showed that chemotherapy-resistant diffuse, large B-cell lymphoma cells can be reprogrammed and treated with azacitidine chemotherapy.

  • “focus on…” session: transformation.  // Annals of Oncology;Jun2008 Supplement 4, Vol. 19, piv111 

    This section presents abstracts on oncology-related topics including the gene and protein expression in transformed diffuse large B cell lymphomas, changes in follicular lymphoma and the prognosis of follicular lymphoma following histologic transformation.

  • MYC Immunohistochemistry Assessment in High-Grade Lymphomas: Hit or Miss? Bigras, Gilbert // American Journal of Clinical Pathology;Feb2016, Vol. 145 Issue 2, p155 

    The author presents insights on the use of MYC immunohistochemistry assessment in diagnosing high-grade lymphomas. He states that 10 to 15% of diffuse large cell B-Cell lymphomas (DLBCL) are MYC driven. He cites a study which describes an IHC method for identifying DLBCL with increased MYC...

  • Identification of MNDA as a new marker for nodal marginal zone lymphoma. Kanellis, G.; Roncador, G.; Arribas, A.; Mollejo, M.; Montes-Moreno, S.; Maestre, L.; Campos-Martin, Y.; Ríos Gonzalez, J. L.; Martinez-Torrecuadrada, J. L.; Sanchez-Verde, L.; Pajares, R.; Cigudosa, J. C.; Martin, M. C.; Piris, M. A. // Leukemia (08876924);Oct2009, Vol. 23 Issue 10, p1847 

    Clinical and biological studies on nodal marginal zone lymphoma (NMZL) are hampered by the lack of specific diagnostic markers and the low reproducibility of this diagnosis. A comparative expression-profiling study has shown a set of markers to be differentially expressed in NMZL compared with...

  • Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. Papoudou-Bai, Alexandra; Hatzimichael, Eleftheria; Barbouti, Alexandra; Kanavaros, Panagiotis // Clinical & Experimental Medicine;Aug2017, Vol. 17 Issue 3, p291 

    The activator protein-1 (AP-1) is a dimeric transcription factor composed of proteins belonging to the Jun (c-Jun, JunB and JunD), Fos (c-Fos, FosB, Fra1 and Fra2) and activating transcription factor protein families. AP-1 is involved in various cellular events including differentiation,...

  • Proteomics Based Identification of Proteins with Deregulated Expression in B Cell Lymphomas. Wu, Rui; Nijland, Marcel; Rutgers, Bea; Veenstra, Rianne; Langendonk, Myra; van der Meeren, Lotte E.; Kluin, Philip M.; Li, Guanwu; Diepstra, Arjan; Chiu, Jen-Fu; van den Berg, Anke; Visser, Lydia // PLoS ONE;1/11/2016, Vol. 11 Issue 1, p1 

    Follicular lymphoma and diffuse large B cell lymphomas comprise the main entities of adult B cell malignancies. Although multiple disease driving gene aberrations have been identified by gene expression and genomic studies, only a few studies focused at the protein level. We applied 2...

  • Fc?RIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP). Camilleri-Broët, S.; Mounier, N.; Delmer, A.; Brière, J.; Casasnovas, O.; Cassard, L.; Gaulard, P.; Christian, B.; Coiffier, B.; Sautès-Fridman, C. // Leukemia (08876924);Dec2004, Vol. 18 Issue 12, p2038 

    Presents a letter to the editor about the role of gene expression in diffusing large B-cell lymphomas.

  • Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas. Zam&ò, Alberto; Malpeli, Giorgio; Scarpa, Aldo; Doglioni, Claudio; Chilosi, Marco; Menestrina, Fabio // Modern Pathology;Nov2005, Vol. 18 Issue 11, p1448 

    Primary mediastinal large B-cell lymphoma is a well-defined lymphoma entity whose molecular pathogenesis is incompletely understood and also lacking well-established diagnostic markers. Recently, the presence of overlapping features between classical Hodgkin's lymphoma and primary mediastinal...

  • MicroRNAs and lymphomas. Croce, C. M. // Annals of Oncology;Jun2008 Supplement 4, Vol. 19, piv39 

    The article explains the link between microribonucleic acid (microRNA) and lymphomas. MicroRNA are small non-coding RNA that regulate the expression of target messenger RNA. They play a significant role in cell cycle, apoptosis and differentiation. Studies have shown that microRNA is associated...

  • Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy. Kawamura, Kiyoko; Wada, Akihiko; Wang, Ji-Yang; Li, Quanhai; Ishii, Akihiro; Tsujimura, Hideki; Takagi, Toshiyuki; Itami, Makiko; Tada, Yuji; Tatsumi, Koichiro; Shimada, Hideaki; Hiroshima, Kenzo; Tagawa, Masatoshi // Journal of Cancer Research & Clinical Oncology;Jan2016, Vol. 142 Issue 1, p27 

    Purpose: Activation-induced cytidine deaminase (AID) is involved in somatic hypermutation and class switch recombination processes in the antibody formation. The AID activity induces gene mutations and could be associated with transformation processes of B cells. Nevertheless, the relation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics